Discover and read the best of Twitter Threads about #NotYetPeerReviewed

Most recents (6)

The latest results from @theSANBS, @The_WCBS, and #SACEMA on anti-SARS-CoV-2 seroprevalence among blood donors in South Africa are now available.

researchsquare.com/article/rs-168…

#notyetpeerreviewed

[1/8]
Congrats to @laurettemhlanga, @alex_welte, @Marionvermeulen, and the rest of the team!

TL;DR: as of mid-March 2022, prior to the BA.4/BA.5-driven resurgence, an estimated 98% of South Africans had antibodies from prior infection, vaccination, or both.

#notyetpeerreviewed

[2/8]
This round of samples was tested using assays that detect different antibody types.

#notyetpeerreviewed

[3/8]
Read 8 tweets
[Thread] South Africa has seen a recent rapid rise in #SARSCoV2 cases & unprecedented number of reinfections.

We've been working on bounding the levels of transmissibility & immune evasion that could explain #Omicron's spread in 🇿🇦.

sacmcepidemicexplorer.co.za/downloads/Pear…

#NotYetPeerReviewed
We find that #Omicron is likely more transmissible than #Delta. This finding holds across a wide range of assumptions about immune evasion that are consistent with early neutralization studies.

Our analysis includes several steps.

#NotYetPeerReviewed Fig 4: Estimated transmissibility & immune evasion relations
First, we analyze trends in S-gene target failure (SGTF) at the provincial level. SGTF is a marker of #Omicron sublineage BA.1. Our updated model accounts for SGTF being an imperfect marker, & we now fit the model to data through 6 December.
Read 14 tweets
UPDATE #Omicron

On ne sait toujours pas grand chose avec certitude, mais ça se précise

Thread court (plus sérieux que les 3 lignes du précédent)

Attention : #NotYetPeerReviewed
Il semble que le variant #omicron puisse réinfecter plus facilement (x 2,5 - 3 ?) les patients qui ont déjà été atteint par le #SARS_CoV_2 ce qui suggère que son avantage compétitif sur #delta pourrait provenir partiellement de cette caractéristique.

NĂ©anmoins l'Ă©tude qui le dit est encore en preprint.

Cette Ă©tude ne donne pas non plus d'information sur le statut vaccinal des individus inclus, ce qui ne permet donc pas d'Ă©valuer le risque d'Ă©chappement au vaccin de #Omicron
doi.org/10.1101/2021.1…
Read 16 tweets
As discussed at #EPIDEMICS8 breakout session, @saCOVID19mc have started characterizing the #SARSCoV2 variant #Omicron; working estimates for this new variant are critical so the globe can plan with the best information possible: drive.google.com/file/d/1hA6Mec…

#NotYetPeerReviewed
Based on S-Gene Target Failure (SGTF), we estimated #Omicron growth rate across RSA provinces. Gauteng has the clearest signal, and indicates growth of 0.21 (0.14, 0.27)/day, corresponding to a doubling time of 3.3 (2.5, 4.6) days.

#NotYetPeerReviewed
From that, we estimated relative effective reproductive #s for #Omicron & #Delta. In Gauteng, the ratio is ~2.4 (2.0, 2.7), assuming #Omicron has the same typical time between generations.

[n.b. this corrects fig from pres.; no change to other results]
#NotYetPeerReviewed
Read 6 tweets
[Thread] We have updated our preprint on SARS-CoV-2 reinfection trends in South Africa to include data through late November. @hivepi @jd_mathbio @carivs @Dr_Groome @nicd_sa #SACEMA

doi.org/10.1101/2021.1…

#notyetpeerreviewed
We find evidence of increased reinfection risk associated with emergence of the #Omicron variant, suggesting evasion of immunity from prior infection. @scienceSUN @NRF_News Daily numbers of detected primary infections, individuals el
We developed 2 methods to monitor signatures of changes in reinfection risk & have used them to monitor reinfection trends in SA since Jan 2021.
Read 13 tweets
@theSANBS, @The_WCBS, and #SACEMA have released new information on SARS-CoV-2 seroprevalence among blood donors in South Africa, including in the 5 provinces for which data were not previously available. #NotYetPeerReviewed

A full preprint will be released soon.
The new data are based on samples collected in May 2021, using the same methods as described in the earlier preprint from Sykes et al:

researchsquare.com/article/rs-233…

The study was led by @Marionvermeulen with data analysis by @laurettemhlanga, Dr Eduard Grebe, and Prof Alex Welte.
The study is primarily funded by @theSANBS and @The_WCBS. #SACEMA and its researchers are funded by @dsigovza and @NRF_News.

The study used the @Roche Elecsys platform, which detects antibodies produced by natural infection that bind to the N protein of the SARS-CoV-2 virus.
Read 8 tweets

Related hashtags

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!